Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $41.93 million, and the earnings are expected to come in at $0.03 per share. The full year 2024's revenue is expected to be $156.94 million and the earnings are expected to be -$0.29 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 5 Warning Signs with RIGL. Over the past 90 days, revenue estimates for Rigel Pharmaceuticals Inc ( NASDAQ:RIGL ) for the full year 2024 have increased from $151.43 million to $156.94 million, and for 2025 from $190.75 million to $194.94 million. Similarly, earnings estimates have shown an upward trend, moving from -$0.86 per share to -$0.29 per share for the full year 2024, and from $0.28 per share to $0.61 per share for 2025. In the previous quarter of June 30, 2024, Rigel Pharmaceuticals Inc's ( NASDAQ:RIGL ) actual revenue was $36.84 million, which beat analysts' revenue expectations of $33.42 million by 10.24%. Rigel Pharmaceuticals Inc's ( NASDA
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Cantor Fitzgerald from $15.00 to $25.00. They now have a "neutral" rating on the stock.MarketBeat
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.MarketBeat
- Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition [Yahoo! Finance]Yahoo! Finance
- Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and ExpositionPR Newswire
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at B. Riley from $17.00 to $27.00. They now have a "neutral" rating on the stock.MarketBeat
RIGL
Earnings
- 11/7/24 - Beat
RIGL
Sec Filings
- 12/9/24 - Form 8-K
- 11/26/24 - Form 4
- 11/26/24 - Form 4
- RIGL's page on the SEC website